VIM and B-cell chronic lymphocytic leukemia: Interestingly, Ig014 reacted much stronger with stroma-derived vimentin as compared to vimentin from other cell lines, possibly indicating that stroma-specific post-translational modifications could be preferentially recognized by this CLL BCR.